Another element that sets digital therapeutics apart was outlined by Ben Lewis, CEO of Limbix, a developer of prescription digital therapeutics, who told pharmaphorum that the company has a ...

Jessica Lake, chief science officer at Limbix, tells us about SparkRx, a digital therapeutics app aimed to help treat adolescent depression. SparkRx is designed to decrease depression in ...

The Digital Therapeutics Market is valued at USD 4.8 Billion in 2022 and is expected to reach USD 18.72 Billion by 2030 at a CAGR of 30.08% over the forecast period 2023-2030. Overview of the Digital ...

Lupin Digital Health marked the company’s foray into the fast-growing digital therapeutics space. Its Lyfe platform focuses on real-time monitoring of patients and offers interventions for ...

The digital therapeutics (DTx) market is experiencing significant growth with a projected CAGR of 25-27% over the next few years. Key drivers include the increasing prevalence of chronic diseases, ...

This is part of a growing industry trend towards the use of digital therapeutics. Hyfe’s technology, developed in partnership with KYORIN Pharmaceutical Co., makes it possible for patients to monitor ...

Digital therapeutics coupled with drugs has the potential to transform health care and change the way patients are treated, Anthony Costello, CEO of Medidata Solutions Inc., told BioWorld. Medidata ...

The American Telemedicine Association’s lobbying arm, ATA Action, acquired the Digital Therapeutics Alliance (DTA) in a bid to beef up its digital health presence and advocate for health ...

The U.S. digital therapeutics market size was valued at $1.16 billion in 2019 and is expected to reach $5.08 billion by 2027 with a CAGR of 19.2% during the forecast period. Increase in adoption of ...

"Our digital therapeutics and pharmacy services are designed to meet patients where they are, breaking down barriers to recovery." Joseph Hensley, PharmD, CPGX, BCMAS, Pharmacist-in-Charge ...

Click Therapeutics has collected a groundbreaking green light from the FDA for the agency’s first prescription digital therapeutic aimed at preventing migraines. Designed to be used alongside ...

The global digital therapeutics market was valued at $2.88 billion in 2019, and is expected to reach $13.80 billion by 2027 with a CAGR of 20.5% during the forecast period. Increase in adoption of ...